AI-Enhanced Cardiology Takes Another Step Forward

John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, senior research analyst and communications specialist, Mayo Clinic Platform, wrote this article. Asymptomatic left ventricular systolic dysfunction (ALVSD) may not be the most familiar disorder in medicine, but it nonetheless increases a patient's risk of heart failure and death. Unfortunately, ALVSD is not that easily detected. Characterized by low ejection fraction (EF) -- a measure of how much blood the heart pumps out during each contraction -- it's readily diagnosed with an echocardiogram. But because the procedure is expensive, it's not recommended as routine screening for the general public.